OURA Ring Wearable Testing in MDS Patients: a Feasibility and Discovery Pilot Study

Launched by SUNNYBROOK HEALTH SCIENCES CENTRE · Feb 14, 2024

Keywords

ClinConnect Summary

This clinical trial, titled "OURA Ring Wearable Testing in MDS Patients," is exploring whether using the OURA ring—a smart wearable device—can help monitor the health and quality of life of adults with Myelodysplastic Syndromes (MDS). In this study, participants will wear the OURA ring for about three months and share their health data each week. The researchers want to see if patients can wear the ring at least 70% of the time and how this data relates to their overall well-being.

To be eligible for the trial, participants must be adults aged 18 or older, diagnosed with MDS according to specific medical guidelines, and able to understand and follow study instructions in English or French. They should also be comfortable using a smartphone and the OURA ring app. Participants can expect to wear the ring regularly, share their health information, and participate in assessments to evaluate their quality of life. This study is not yet recruiting, but it aims to boost understanding of how technology can support patients living with MDS.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Provision of signed and dated informed consent form
• • 2. Stated willingness to comply with all study procedures and availability for the duration of the study
• • 3. Male or female, aged 18 or older
• • 4. Able to read, write and speak English or French (non-English or French speaking patients may participate if appropriate translation is used)
• • 5. Diagnosed with Myelodysplastic Syndrome using WHO 2022 criteria (12) all risk groups
• • 6. Ability to wear the OURA ring and operate the associated smart-phone app, and willing to adhere to the study regimen
• Exclusion Criteria:
• • 1. Performance status ECOG \> 3.
• • 2. Cognitive or physical impairment preventing the usage or utilization of the OURA ring and smart phone.